Takeaway
The expression of GSDMD, an executive protein of pyroptosis, is increased in cerebrospinal fluid of people with Alzheimer’s disease.
Why this matters ?
The increased expression of GSDMD in cerebrospinal fluid of people with Alzheimer’s disease supports its use as a biomarker for disease; it could also assist with the differential diagnosis of Alzheimer’s disease and vascular dementia.